Overview
Makoto Urushitani practices in Otsu, Japan. Mr. Urushitani is rated as an Experienced expert by MediFind in the treatment of Erythema Nodosum. His top areas of expertise are Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Primary Lateral Sclerosis, Multifocal Motor Neuropathy, and Multiple System Atrophy.
His clinical research consists of co-authoring 88 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Erythema Nodosum.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease)
- Primary Lateral SclerosisMr. Urushitani isElite. Learn about Primary Lateral Sclerosis.
- Advanced
- Multifocal Motor NeuropathyMr. Urushitani isAdvanced. Learn about Multifocal Motor Neuropathy.
- Experienced
- Alzheimer's DiseaseMr. Urushitani isExperienced. Learn about Alzheimer's Disease.
- Aphthous StomatitisMr. Urushitani isExperienced. Learn about Aphthous Stomatitis.
- Breast Enlargement In MalesMr. Urushitani isExperienced. Learn about Breast Enlargement In Males.
- CACH SyndromeMr. Urushitani isExperienced. Learn about CACH Syndrome.
- Canker SoreMr. Urushitani isExperienced. Learn about Canker Sore.
- Cerebellar Multiple System AtrophyMr. Urushitani isExperienced. Learn about Cerebellar Multiple System Atrophy.